CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 26 of 48

Rheumatology (Oxford)

Briefs 1,001–1,040 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis

    Cohort studySystemic sclerosis

  2. Rheumatology (Oxford)

    Development of a measuring app for systemic sclerosis-related digital ulceration (SALVE: Scleroderma App for Lesion VErification)

    Research articleSystemic sclerosis

  3. Rheumatology (Oxford)

    Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical–serological–pathological classification

    Cohort studyMyositis

  4. Rheumatology (Oxford)

    Subclinical aortic inflammation in patients with polymyalgia rheumatica

    Cohort studyVasculitis & PMR

  5. Rheumatology (Oxford)

    Trimethoprim sulfamethoxazole prophylaxis and serious infections in granulomatosis with polyangiitis treated with rituximab

    Cohort studyVasculitis & PMR

  6. Rheumatology (Oxford)

    Do functionality, strength, vascularization, inflammatory and biopsychosocial status improve by biopsychosocial model-based exercise in SSc?

    Research articleSystemic sclerosis

  7. Rheumatology (Oxford)

    HLA-B5 prevalence in patients with spondyloarthritis and impact on disease phenotype: a multicentric case–control study

    Case-control studySpondyloarthritis & PsA

  8. Rheumatology (Oxford)

    Long-term outcomes of childhood-onset systemic lupus erythematosus

    Cohort studyPediatric

  9. Rheumatology (Oxford)

    The impact of periodontitis and periodontal treatment on rheumatoid arthritis outcomes: an exploratory clinical trial

    Randomized controlled trialRA

  10. Rheumatology (Oxford)

    Avacopan for anti-neutrophil cytoplasm antibodies-associated vasculitis: a multicentre real-world study

    Cohort studyVasculitis & PMR

  11. Rheumatology (Oxford)

    A double-blind, placebo-controlled, randomized multiple dose phase 1b trial of a CDK4/6 inhibitor, TCK-276, in patients with active rheumatoid arthritis

    Randomized controlled trialRA

  12. Rheumatology (Oxford)

    Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis

    Cohort studyVasculitis & PMR

  13. Rheumatology (Oxford)

    Refining treat-to-target strategies in cryopyrin-associated periodic syndromes: the role of inflammatory markers

    Cohort studyAutoinflammatory & rare

  14. Rheumatology (Oxford)

    Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score

    Diagnostic or prognostic studyPediatric

  15. Rheumatology (Oxford)

    Could tocilizumab be used in familial Mediterranean fever? A systematic review

    Meta-analysisAutoinflammatory & rare

  16. Rheumatology (Oxford)

    Microwave ablation of synovial hypertrophy in recurrent monoarthritis: the results of extended cohort and long-term follow-up

    Cohort study

  17. Rheumatology (Oxford)

    Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after 2 years?

    Cohort studySpondyloarthritis & PsA

  18. Rheumatology (Oxford)

    A machine learning-based prediction model for gout in hyperuricemics: a nationwide cohort study

    Cohort studyGout & crystals

  19. Rheumatology (Oxford)

    Ultrasound of the forefeet besides the hands in patients at risk for rheumatoid arthritis: is it worth the effort? A longitudinal cohort study

    Cohort studyRA

  20. Rheumatology (Oxford)

    Validation of a questionnaire for central nervous system aspects of joint pain: the CAP questionnaire

    Diagnostic or prognostic studyFibromyalgia & pain

  21. Rheumatology (Oxford)

    Tacrolimus personalized therapy based on CYP3A5 genotype in Chinese patients with idiopathic inflammatory myopathies

    Cohort studyMyositis

  22. Rheumatology (Oxford)

    Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study

    Cohort studyAcross diseases

  23. Rheumatology (Oxford)

    Comparison of anti-IL-6 receptor and JAK inhibitors in patients with rheumatoid arthritis from the real-world practice FIRST registry

    Cohort studyRA

  24. Rheumatology (Oxford)

    Assessment of damage in Takayasu’s arteritis

    Cohort studyVasculitis & PMR

  25. Rheumatology (Oxford)

    Predictive validity of Lupus Patient-Reported Outcome for damage accrual in patients with systemic lupus erythematosus: the LUNA Registry

    Cohort studyLupus & APS

  26. Rheumatology (Oxford)

    Performance of clinical and histological prognostic scores for kidney survival in ANCA-associated vasculitis

    Cohort studyVasculitis & PMR

  27. Rheumatology (Oxford)

    Plasma interferon-alpha protein levels during pregnancy are associated with lower birth weight in systemic lupus erythematosus

    Cohort studyLupus & APS

  28. Rheumatology (Oxford)

    Effect of using the Simple Erosion Narrowing Score or Sharp/van der Heijde score on the power of rheumatoid arthritis clinical trials to detect differences in radiographic progression

    Secondary analysisRA

  29. Rheumatology (Oxford)

    Incidence of juvenile idiopathic arthritis in Finland, 2000–2020

    Research articlePediatric

  30. Rheumatology (Oxford)

    Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis

    Cohort studyRA

  31. Rheumatology (Oxford)

    One-year effectiveness of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations

    Randomized controlled trialSpondyloarthritis & PsA

  32. Rheumatology (Oxford)

    The value of axillary, facial, occipital, subclavian and common carotid arteries ultrasound in the diagnosis of giant cell arteritis

    Cohort studyVasculitis & PMR

  33. Rheumatology (Oxford)

    Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients

    Cohort studyLupus & APS

  34. Rheumatology (Oxford)

    FTY720 ameliorates experimental MPO-ANCA-associated vasculitis by regulating fatty acid oxidation via the neutrophil PPARα–CPT1a pathway

    Mechanistic studyVasculitis & PMR

  35. Rheumatology (Oxford)

    Prevalence and characteristics of adults with difficult-to-treat rheumatoid arthritis in a large patient registry

    Cross-sectional studyRA

  36. Rheumatology (Oxford)

    Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis

    Cross-sectional studyMyositis

  37. Rheumatology (Oxford)

    Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study

    Cohort studyAcross diseases

  38. Rheumatology (Oxford)

    Which advanced treatment should be used following the failure of a first-line anti-TNF in patients with rheumatoid arthritis? 15 years of evidence from the Quebec registry RHUMADATA

    Cohort studyRA

  39. Rheumatology (Oxford)

    Deep learning in the precise assessment of primary Sjögren’s syndrome based on ultrasound images

    Diagnostic or prognostic studySjögren's & overlap

  40. Rheumatology (Oxford)

    Association of ankylosing spondylitis with the risk of cancer: a meta-analysis of cohort studies

    Meta-analysisSpondyloarthritis & PsA

All 1,905 Briefs in ExploreShowing Briefs 1,001–1,040 of 1,905, newest first